These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3265106

  • 1. D-1/D-2 behavioural interactions in the rat involving striatal dopamine D-1 receptors.
    Starr MS.
    Eur J Pharmacol; 1988 Jul 14; 151(3):479-82. PubMed ID: 3265106
    [Abstract] [Full Text] [Related]

  • 2. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 3. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 10; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 4. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.
    Braun AR, Chase TN.
    Eur J Pharmacol; 1986 Nov 19; 131(2-3):301-6. PubMed ID: 3493161
    [Abstract] [Full Text] [Related]

  • 5. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS, Robertson HA.
    Brain Res; 1986 Oct 08; 384(2):387-90. PubMed ID: 2946360
    [Abstract] [Full Text] [Related]

  • 6. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
    Starr MS, Starr BS.
    Pharmacol Biochem Behav; 1989 May 08; 33(1):41-4. PubMed ID: 2571171
    [Abstract] [Full Text] [Related]

  • 7. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 08; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 8. Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study.
    Hu XT, Wang RY.
    J Neurosci; 1988 Nov 08; 8(11):4340-8. PubMed ID: 2972814
    [Abstract] [Full Text] [Related]

  • 9. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
    Morelli M, Fenu S, Di Chiara G.
    Life Sci; 1987 Jan 19; 40(3):245-51. PubMed ID: 2948094
    [Abstract] [Full Text] [Related]

  • 10. The influence of repeated treatment with imipramine, (+)- and (-)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonists.
    Maj J, Papp M, Skuza G, Bigajska K, Zazula M.
    J Neural Transm; 1989 Jan 19; 76(1):29-38. PubMed ID: 2565359
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A, Tanda G, Frau R, Di Chiara G.
    J Pharmacol Exp Ther; 1988 Apr 19; 245(1):257-64. PubMed ID: 3258912
    [Abstract] [Full Text] [Related]

  • 12. Behavioral effects of chronic exposure to selective D-1 and D-2 dopamine receptor agonists.
    Braun AR, Chase TN.
    Eur J Pharmacol; 1988 Mar 15; 147(3):441-51. PubMed ID: 3259931
    [Abstract] [Full Text] [Related]

  • 13. SKF 38393 potentiates yawning induced by LY 171555: further evidence against the autoreceptor hypothesis of yawning.
    Spina L, Longoni R, Mulas A, Di Chiara G.
    Psychopharmacology (Berl); 1989 Mar 15; 98(4):567-8. PubMed ID: 2570436
    [Abstract] [Full Text] [Related]

  • 14. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 15. Changes in motor activities induced by microinjections of the selective dopamine agonists LY 171555, quinpirole hydrochloride, and SK&F 38393 into the habenula nucleus.
    Thornton EW, Evans JA, Wickens A.
    Pharmacol Biochem Behav; 1987 Mar 07; 26(3):643-6. PubMed ID: 3495009
    [Abstract] [Full Text] [Related]

  • 16. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR, Napier TC, Mueller RA.
    J Pharmacol Exp Ther; 1985 Aug 07; 234(2):447-55. PubMed ID: 3926987
    [Abstract] [Full Text] [Related]

  • 17. Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade.
    Barone P, Tucci I, Parashos SA, Chase TN.
    Eur J Pharmacol; 1988 May 10; 149(3):225-32. PubMed ID: 3261693
    [Abstract] [Full Text] [Related]

  • 18. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
    Carlson JH, Bergstrom DA, Demo SD, Walters JR.
    Eur J Pharmacol; 1988 Aug 02; 152(3):289-300. PubMed ID: 2906003
    [Abstract] [Full Text] [Related]

  • 19. Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity.
    Morelli M, Fenu S, Garau L, Di Chiara G.
    Eur J Pharmacol; 1989 Mar 21; 162(2):329-35. PubMed ID: 2566500
    [Abstract] [Full Text] [Related]

  • 20. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
    Breese GR, Baumeister A, Napier TC, Frye GD, Mueller RA.
    J Pharmacol Exp Ther; 1985 Nov 21; 235(2):287-95. PubMed ID: 3932640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.